SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-11-008573
Filing Date
2011-05-24
Accepted
2011-05-24 19:06:32
Documents
2
Period of Report
2011-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3041
2 POWER OF ATTORNEY brinkley-poa.txt EX-24.TXT 3503
  Complete submission text file 0001179110-11-008573.txt   7950
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Brinkley David L (Reporting) CIK: 0001302445 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 11869185